Concerted Care Group (CCG), a CARF-accredited opioid treatment program (OTP) serving consumers across the full spectrum of socioeconomic levels in Maryland, today announced that Dr. Andrey Ostrovsky, the recent Chief Medical Officer for the Center for Medicaid and CHIP Services (CMCS), is joining CCG as its Chief Executive Officer and President.

Dr. Ostrovsky is a technology entrepreneur who was recruited by the Obama administration to accelerate innovation and efficiency in the federal Medicaid program after he sold his healthcare technology company in 2016. During his tenure in the federal government, Dr. Ostrovsky publicly advocated for Medicaid beneficiaries by opposing efforts to cut Medicaid.

After experiencing the loss of his uncle at the hand of the same opioid epidemic plaguing the country, Dr. Ostrovsky decided to take his focus to the local level by joining an innovative treatment center in the heart of Baltimore City. As CEO of CCG, Dr. Ostrovsky will guide the strategic vision and growth of the organization to expand beyond Baltimore's borders and open new facilities across the state and country.

"After seeing the opioid epidemic explode on a national level and to then experience personal loss, I'm inspired to be joining CCG at a time when the city, state and nation need a new approach to handling opioid use disorder," said Dr. Ostrovsky. "As CEO of CCG, I plan to extend the program's reach beyond Baltimore into other cities and states. We need to break down the stigma around addiction and realize that people from all socioeconomic levels are suffering from this epidemic and deserve access to the highest quality addiction treatment."

In addition to expanding to new locations, CCG is partnered with the healthcare investment group IFG88 to finance and pilot socially responsible, outcomes-based solutions to the country's most challenging public health problems. Dr. Ostrovsky notes that, "CCG is a center of clinical excellence that can serve as a platform for validating and scaling transformative behavioral health technologies. The CCG platform will also be a sandbox for working with a broadening array of payers to test delivery system innovations that will accelerate behavioral healthcare toward value based payment."

Established in 2014, Concerted Care Group was built on a foundation of providing comprehensive services to patients looking to beat addiction. Founded by Noah Nordheimer, former CEO and current Chairman of the Board, CCG is a safe haven for people with substance use disorder looking to access gold-standard medication assisted treatment and begin the process of recovery.

"The decision to bring Dr. Ostrovsky on to lead CCG's expansion was an easy one. His technical background, proficiency in innovation and dedication to serving the underserved made him the obvious candidate," said Noah Nordheimer, Chairman of the Board of CCG and co-managing partner of IFG88. "We are in an exciting phase of the company's journey and with Dr. Ostrovsky at the helm, we will be beating our goals and then some."

About Concerted Care Group:

CCG is a technology-enabled and evidence-based addiction treatment program which comprehensively integrates primary care and social services to address all health determinants for its clients. Headquartered in Baltimore, MD, CCG is CARF-accredited as an OTP to deliver medication assisted treatment (MAT), is licensed as an Outpatient Mental Health Clinic (OMHC), and is licensed as a primary care clinic.